People - September 2004
Merrion Pharmaceuticals, a new speciality pharmaceutical company has appointed three key members of its management team. John Lynch, managing director, and Joey Moodley, director of operations, have joined Merrion Biopharma, the company's r&d headquarters, located in Dublin, Ireland. The third appointment is that of Dr Thomas W. Leonard as vice president and chief scientific officer, Merrion Pharmaceuticals, of Wilmington, North Carolina. Lynch and Moodley were previously with Abbott Laboratories and Elan respectively, while Leonard was formerly vice president and cso at Endeavour Pharmaceuticals.
Lauren Schulte has been names sales and marketing manager for the internal start-up Degussa Homogeneous Catalysts. She will be responsible for global market development and sales growth of homogeneous catalysts in the fine chemicals and life sciences sectors.
Malvern Instruments has promoted Laurent Lachmanski to the new position of European sales manager for the company's range of vision systems, following Malvern's recent acquisition of the technology and manufacturing rights for the PharmaVision 830. Lachmanski, who has served five highly successful years as one of Malvern's sales and technical support territory managers, will be based in the Malvern France office in Paris.
Marchesini USA has appointed Roger Toll as company director. He was managing director of Marchesini UK, a position now occupied by Andrew Long, who was previously sales manager for the UK company. Kevan Bayes replaces Long as sales manager.
Dr Uwe Gottschalk has been appointed vice president for the new purification technologies unit within the bioprocess business area of the biotechnology division at Sartorius. Dr Gottschalk has extensive experience in the pharmaceutical industry, most recently as head of protein purification at Bayer Health Care.
French immunotherapeutics specialist Avidis has made a number of appointments to its management committee: Francois Miceli, ceo; Dr Fergal Hill, executive director, research and intellectual property; and Dr Michel Wurm, executive director of business and preclinical development. The appointments follow a number of deals with big players in the vaccine market, good laboratory results, and a small injection of capital.
Two senior management appointments have been made by Rieke Packaging Systems, Englass. Warren Wharton and Nick Larcombe have joined the company as sales and marketing director and business development director respectively. Wharton was previously with the plastic closure business of Alcoa CSI UK and Larcombe was formerly sales director of contract filler Czewo.